Pharmacy- Page 70

Roche ranked the most sustainable healthcare company in the DJSI

November 16, 2020
The FINANCIAL — For the eleventh time, Roche has been recognised as the most sustainable company in the Pharmaceuticals index of the Dow Jones Sustainability Indices (DJSI). This is based on an in-depth analysis of economic, social and environmental performance. The DJSI family of indices serves as a benchmark for investors who integrate sustainability considerations into their portfolios. Roche has

New data from pivotal study showed Roche’s Gazyva/Gazyvaro induced deep remissions and provided meaningful quality of life improvements in people with difficult-to-treat indolent non-Hodgkin lymphoma

The FINANCIAL -- Roche on December 7 announced follow-up results from the pivotal phase III GADOLIN study in people with indolent non-Hodgkin lymphoma (iNHL) who relapsed during or within six months after treatment with a MabThera/Rituxan (rituximab)-based regimen. In a subgroup analysis of
December 7, 2015
1 min read

Changes in Roche Board of Directors

The FINANCIAL -- At its December meeting, the Board of Directors (BoD) of Roche Holding decided on first proposals for approval by the Annual General Meeting (AGM), scheduled for 1 March 2016. Professor Dr Beatrice Weder di Mauro, a member of the
December 7, 2015
1 min read

Pivotal Phase II study showed nearly 80 percent of people with hard-to-treat type of chronic lymphocytic leukaemia responded to investigational medicine venetoclax

The FINANCIAL -- Roche on December 7 announced new, positive data from the Phase II M13-982 study of venetoclax, an investigational medicine being developed in partnership with AbbVie. Results of the study showed a clinically meaningful reduction in the number of cancer cells (overall
December 7, 2015
2 mins read
1 … 68 69 70 71 72 … 195

Get updates

Join

We hate spams like you do

Latest comments

Go toTop